These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 39018093)

  • 1. Advancing Colorectal Cancer Detection With Blood-Based Tests: Qualitative Study and Discrete Choice Experiment to Elicit Population Preferences.
    Ong C; Cook AR; Tan KK; Wang Y
    JMIR Public Health Surveill; 2024 Jul; 10():e53200. PubMed ID: 39018093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
    Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
    Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An empirical comparison of methods for analyzing correlated data from a discrete choice survey to elicit patient preference for colorectal cancer screening.
    Cheng J; Pullenayegum E; Marshall DA; Marshall JK; Thabane L
    BMC Med Res Methodol; 2012 Feb; 12():15. PubMed ID: 22348526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preferences of Iranian average risk population for colorectal cancer screening tests.
    Ramezani Doroh V; Delavari A; Yaseri M; Emamgholipour Sefiddashti S; Akbarisari A
    Int J Health Care Qual Assur; 2019 May; 32(4):677-687. PubMed ID: 31111783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preferences for potential innovations in non-invasive colorectal cancer screening: A labeled discrete choice experiment for a Dutch screening campaign.
    Benning TM; Dellaert BG; Dirksen CD; Severens JL
    Acta Oncol; 2014 Jul; 53(7):898-908. PubMed ID: 24456499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the Preferences and Considerations of the Public Towards Risk-Stratified Screening for Colorectal Cancer: Insights From Think-Aloud Interviews Based on a Discrete Choice Experiment.
    Dennison RA; Clune RJ; Morris S; Thomas C; Usher-Smith JA
    Health Expect; 2024 Aug; 27(4):e14153. PubMed ID: 39030943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneous Preferences for Colorectal Cancer Screening in Germany: Results of a Discrete Choice Experiment.
    Brinkmann M; Diedrich L; Hemmerling M; Krauth C; Robra BP; Stahmeyer JT; Dreier M
    Value Health; 2023 Jan; 26(1):104-114. PubMed ID: 36031478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
    Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
    Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colorectal cancer screening preferences among physicians and individuals at average risk: A discrete choice experiment.
    Heidenreich S; Finney Rutten LJ; Miller-Wilson LA; Jimenez-Moreno C; Chua GN; Fisher DA
    Cancer Med; 2022 Aug; 11(16):3156-3167. PubMed ID: 35315224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public Heterogeneous Preferences for Low-Dose Computed Tomography Lung Cancer Screening Service Delivery in Western China: A Discrete Choice Experiment.
    Tao W; Bao T; Gu T; Pan J; Li W; Li R
    Int J Health Policy Manag; 2024; 13():8259. PubMed ID: 39099484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimating the preferences and willingness-to-pay for colorectal cancer screening: an opportunity to incorporate the perspective of population at risk into policy development in Thailand.
    Phisalprapa P; Ngorsuraches S; Wanishayakorn T; Kositamongkol C; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2021; 24(1):226-233. PubMed ID: 33467947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
    Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
    Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival or Mortality: Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?
    Veldwijk J; Essers BA; Lambooij MS; Dirksen CD; Smit HA; de Wit GA
    Value Health; 2016; 19(2):202-9. PubMed ID: 27021754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
    Benning TM; Dellaert BG; Severens JL; Dirksen CD
    Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. "Finding the Right FIT": Rural Patient Preferences for Fecal Immunochemical Test (FIT) Characteristics.
    Pham R; Cross S; Fernandez B; Corson K; Dillon K; Yackley C; Davis MM
    J Am Board Fam Med; 2017; 30(5):632-644. PubMed ID: 28923816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a discrete choice experiment to inform the design of programs to promote colon cancer screening for vulnerable populations in North Carolina.
    Pignone MP; Crutchfield TM; Brown PM; Hawley ST; Laping JL; Lewis CL; Lich KH; Richardson LC; Tangka FK; Wheeler SB
    BMC Health Serv Res; 2014 Nov; 14():611. PubMed ID: 25433801
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence.
    Forbes SP; Yay Donderici E; Zhang N; Sharif B; Tremblay G; Schafer G; Raymond VM; Talasaz A; Eagle C; Das AK; Grady WM
    J Med Econ; 2024; 27(1):991-1002. PubMed ID: 39037853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Tailored Interventions on Receipt of a Preference-Concordant Colorectal Cancer Screening Test.
    Christy SM; Monahan PO; Stump TE; Rawl SM; Champion VL
    Med Decis Making; 2020 Jan; 40(1):29-41. PubMed ID: 31814511
    [No Abstract]   [Full Text] [Related]  

  • 19. Eliciting population preferences for mass colorectal cancer screening organization.
    Nayaradou M; Berchi C; Dejardin O; Launoy G
    Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does attribute framing in discrete choice experiments influence willingness to pay? Results from a discrete choice experiment in screening for colorectal cancer.
    Howard K; Salkeld G
    Value Health; 2009; 12(2):354-63. PubMed ID: 18657102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.